Pacira BioSciences, Inc. PCRX
36.48 USD 0.00 (+0.00%)
Regular-session close
36.48 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
36.48 Day range 36.49
18.80 52-week range 36.67
- YTD
- 0.00%
- 1 year
- 0.00%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 726.41M | 700.97M | 674.98M | 666.82M | 541.53M | |
| 576.66M | 530.54M | 490.31M | 467.53M | 401.28M | |
| 19.19M | -73.37M | 87.67M | 60.02M | 89.92M | |
| 7.03M | -99.56M | 41.95M | 15.91M | 41.98M | |
| 0.16 | -2.15 | 0.89 | 0.34 | 0.92 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 158.54M | 276.77M | 153.30M | 104.14M | 585.58M | |
| 1.26B | 1.55B | 1.57B | 1.68B | 2.08B | |
| 571.81M | 775.17M | 704.26M | 906.19M | 1.34B | |
| 418.20M | 638.85M | 586.04M | 763.39M | 1.13B | |
| 693.11M | 778.35M | 870.13M | 775.01M | 730.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 151.99M | 189.39M | 154.65M | 145.27M | 125.72M | |
| 99.48M | -83.28M | 77.54M | -225.19M | -20.79M | |
| -369.63M | 17.36M | -183.03M | -401.53M | 380.69M | |
| -15.33M | -10.64M | -15.16M | -30.08M | -45.87M | |
| -118.23M | 123.48M | 49.16M | -481.44M | 485.62M |
